Search Results
Pembro + Gem & concurrent hypofractionated RT as bladder sparing treatment for MIBC
Phase-2 trial of gemcitabine, cisplatin + nivolumab with selective bladder sparing in MIBC patients
Radio-immunotherapy for bladder preservation
Pembrolizumab plus enfortumab vedotin for bladder cancer
KEYNOTE-992: pembrolizumab plus chemoRT for MIBC
One to watch: KEYNOTE-866, perioperative pembro with neoadjuvant chemo in MIBC
An expert guide: Treating bladder cancer with radiotherapy - Online interview
Trimodal Therapy for Muscle Invasive Bladder Cancer: Practical Aspects and Updates
KEYNOTE-057: extended follow-up of pembrolizumab in bladder cancer
Innovative Therapeutic Solutions in Bladder Cancer: A New Era for Patient Care
MIBC Fall 2021 Recruitment
USI Smart Learning Program 18th September 2020 MIBC
